Billiontoone (NASDAQ:BLLN) Shares Down 6.5% – What’s Next?

Billiontoone, Inc. (NASDAQ:BLLN)’s share price fell 6.5% during trading on Tuesday. The company traded as low as $101.61 and last traded at $101.9420. Approximately 192,399 shares changed hands during trading, a decline of 65% from the average daily volume of 549,552 shares. The stock had previously closed at $109.06.

Wall Street Analysts Forecast Growth

Several research analysts have commented on BLLN shares. Guggenheim upped their price objective on shares of Billiontoone from $125.00 to $128.00 and gave the stock a “buy” rating in a report on Thursday. Zacks Research upgraded shares of Billiontoone from a “strong sell” rating to a “hold” rating in a report on Friday. JPMorgan Chase & Co. cut their price objective on Billiontoone from $145.00 to $130.00 and set an “overweight” rating on the stock in a research report on Thursday, August 6th. Wall Street Zen downgraded Billiontoone from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Finally, Canaccord Genuity Group started coverage on Billiontoone in a research report on Wednesday, September 2nd. They issued a “buy” rating and a $120.00 target price for the company. Seven analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Billiontoone currently has an average rating of “Moderate Buy” and a consensus price target of $126.25.

Billiontoone Price Performance

The stock has a market capitalization of $4.73 billion and a P/E ratio of 143.48. The company has a debt-to-equity ratio of 0.17, a quick ratio of 11.31 and a current ratio of 11.69. The firm has a fifty day moving average price of $106.67 and a two-hundred day moving average price of $100.31.

Billiontoone (NASDAQ:BLLN) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 EPS for the quarter, hitting analysts’ consensus estimates of $0.15. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%.The business had revenue of $109.45 million during the quarter. As a group, analysts expect that Billiontoone, Inc. will post 0.83 EPS for the current fiscal year.

Insider Buying and Selling

In other news, insider Thomas Lynch sold 35,112 shares of the stock in a transaction that occurred on Thursday, September 17th. The stock was sold at an average price of $110.33, for a total value of $3,873,906.96. Following the sale, the insider directly owned 700 shares in the company, valued at approximately $77,231. This represents a 98.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Oguzhan Atay sold 32,500 shares of the company’s stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $136.95, for a total transaction of $4,450,875.00. Following the completion of the transaction, the chief executive officer owned 20,000 shares in the company, valued at approximately $2,739,000. The trade was a 61.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 216,357 shares of company stock valued at $24,589,056. Company insiders own 50.22% of the company’s stock.

Hedge Funds Weigh In On Billiontoone

Large investors have recently bought and sold shares of the business. Adams Street Partners LLC purchased a new stake in shares of Billiontoone during the 4th quarter valued at $140,063,000. Wasatch Advisors LP raised its stake in Billiontoone by 40.2% in the second quarter. Wasatch Advisors LP now owns 518,084 shares of the company’s stock valued at $62,160,000 after buying an additional 148,446 shares during the last quarter. Emerald Advisers LLC boosted its holdings in Billiontoone by 26.8% in the first quarter. Emerald Advisers LLC now owns 239,562 shares of the company’s stock worth $18,911,000 after acquiring an additional 50,613 shares in the last quarter. Capital International Investors purchased a new stake in shares of Billiontoone during the fourth quarter worth about $14,568,000. Finally, Emerald Mutual Fund Advisers Trust grew its stake in shares of Billiontoone by 11.9% during the first quarter. Emerald Mutual Fund Advisers Trust now owns 132,206 shares of the company’s stock worth $10,436,000 after acquiring an additional 14,072 shares during the last quarter.

Billiontoone Company Profile

BillionToOne, Inc (NASDAQ:BLLN) is a molecular diagnostics company that develops blood-based genetic tests designed to provide more information from small amounts of cell-free DNA. The company’s platform uses proprietary molecular counting technology to improve the sensitivity and accuracy of diagnostic testing.

BillionToOne’s primary business is reproductive health testing. Its UNITY portfolio is designed to support prenatal screening, including testing for chromosomal conditions and single-gene disorders, and is intended to provide physicians and expectant parents with information from a maternal blood sample.